Competition is the key to low prices in the pharmaceutical industry. For decades, Americans have benefited from affordable generic versions of brand-name drugs. But now, we stand poised on the wave of a revolution. Biologics, which include lifesaving cancer-treating drugs, can cost hundreds of thousands of dollars per year and are forecast to be the … Continue reading Prof. Michael Carrier published “Don’t Die! How Biosimilar Disparagement Violates Antitrust Law” in the Northwestern University Law Review Online…
Prof. Michael Carrier gives lecture at Harvard
Prof. Michael Carrier presented a lecture on “Three Challenges for Pharmaceutical Antitrust” to Harvard’s Program on Regulation, Therapeutics, and Law.
Prof. Michael Carrier participates in standards panel
Prof. Michael Carrier participated in the panel “New Opportunities for American Leadership in Standards and IP Policy” sponsored by ACT / The App Association
Research Collaboration on Online Political Ad Transparency
Lastowka Short-Form Writing Competition
The Rutgers Institute for Information Policy & Law is pleased to announce the Lastowka Short-Form Writing Competition. Open to Camden-based Rutgers students and recent graduates (class of 2020), the award will be given to an entry of 500-1,500 words on a topic of intellectual property or information policy more broadly. Professor Greg Lastowka (1968-2015) will … Continue reading Lastowka Short-Form Writing Competition…